Clinical Read2026-06-15

Crinecerfont - (CAHtalyst Pediatric Study)

Neurocrine Biosciences Inc.NBIX
Indication
Congenital Adrenal Hyperplasia (CAH) - children
Stage
phase3
Event
Phase 3